Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia-Reference-Cited by-同舟云学术

Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia

Published:2001-06 Issue:6 Volume:15 Page:954-962
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Lezon-Geyda K,Najfeld V,Johnson EM

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2402108.pdf

Reference53 articles.

1. Johansson B, Mertens F, Mitelman F . Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci Genes Chromosomes Cancer 1993 8: 205–218

2. Boultwood J, Fidler C . Chromosomal deletions in myelodysplasia Leuk Lymphoma 1995 17: 71–78

3. Vallespi T, Imbert M, Mecucci C, Preudhomme C, Fenaux P . Diagnosis, classification, and cytogenetics of myelodysplastic syndromes Haematologica 1998 83: 258–275

4. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD . Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7 J Clin Oncol 1986 4: 325–345

5. Zhao N, Stoffel A, Wang PW, Eisenbart JD, Espinosa R 3rd, Larson RA, Le Beau MM . Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1–1.5 Mb and preparation of a PAC-based physical map Proc Natl Acad Sci USA 1997 94: 6948–6953

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Purine-Rich Element Binding Protein Alpha, a Nuclear Matrix Protein, Has a Role in Prostate Cancer Progression;International Journal of Molecular Sciences;2024-06-24

2. Construction of an exosome-associated miRNA-mRNA regulatory network and validation of FYCO1 and miR-17-5p as potential biomarkers associated with ovarian cancer;Translational Cancer Research;2024-02

3. LncRNA AGPG confers endocrine resistance in breast cancer by promoting E2F1 activity;Cancer Research;2023-07-18

4. Neuromuscular and Neuromuscular Junction Manifestations of the PURA-NDD: A Systematic Review of the Reported Symptoms and Potential Treatment Options;International Journal of Molecular Sciences;2023-01-23

5. Forming cytoplasmic stress granules PURα suppresses mRNA translation initiation of IGFBP3 to promote esophageal squamous cell carcinoma progression;Oncogene;2022-08-09